JAMA

Capturing the patient's view of change as a clinical outcome measure.

JAMA

Fischer D, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

JAMA

Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

JAMA

Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR

Alendronate and fracture prevention.

JAMA

Cummings SR, Black D, Barrett-Connor E, Scott J, Wallace RB

Alendronate and fracture prevention.

JAMA

Cummings SR, Black D, Barrett-Connor E, Scott J, Wallace RB

Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.

JAMA

Grumbach K, Selby JV, Damberg C, Bindman AB, Quesenberry C, Truman A, Uratsu C

Resolving the gatekeeper conundrum: what patients value in primary care and referrals to specialists.

JAMA

Grumbach K, Selby JV, Damberg C, Bindman AB, Quesenberry C, Truman A, Uratsu C

Pages